Literature DB >> 29288307

The Value of the C-Reactive Protein-to-Albumin Ratio is Useful for Predicting Survival of Patients with Child-Pugh Class A Undergoing Liver Resection for Hepatocellular Carcinoma.

Takayuki Shimizu1, Mitsuru Ishizuka2, Takashi Suzuki2, Genki Tanaka2, Takayuki Shiraki2, Yuhki Sakuraoka2, Takatsugu Matsumoto2, Masato Kato2, Taku Aoki2, Keiichi Kubota2.   

Abstract

BACKGROUND: Although a recent study has shown that the C-reactive protein-to-albumin ratio (CAR) can predict the survival in patients with hepatocellular carcinoma (HCC), it is unclear whether CAR can predict the survival after surgery.
OBJECTIVE: To investigate the utility of CAR for prediction of postoperative survival among HCC patients with Child-Pugh class A.
METHODS: We retrospectively reviewed 239 patients with Child-Pugh class A who were newly diagnosed with HCC and received initial liver resection. Univariate and multivariate analyses using the Cox proportional hazard model were performed to detect clinical characteristics that correlated with overall survival (OS), and their cutoff values were identified using receiver operating characteristic curve analyses. The cutoff value of CAR was 0.028. Kaplan-Meier analysis and the log-rank test were used for the comparison of OS and disease-free survival (DFS) between two CAR groups (>0.028/≤0.028).
RESULTS: Multivariate analysis using 16 clinical characteristics selected by univariate analyses revealed that CAR (>0.028/≤0.028) (HR, 3.211; 95% CI 1.065-9.680; P = 0.038) was significantly associated with OS, as well as anatomical resection (presence/absence) (HR, 0.275; 95% CI 0.119-0.635; P = 0.275). A significant difference in OS and DFS was observed between patients with low CAR (≤0.028) and patients with high CAR (>0.028).
CONCLUSIONS: CAR is a useful predictor of postoperative survival among HCC patients with Child-Pugh class A.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29288307     DOI: 10.1007/s00268-017-4446-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  41 in total

1.  Prospective validation of the Cancer of the Liver Italian Program (CLIP) score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma.

Authors:  J M Llovet; J Bruix
Journal:  Hepatology       Date:  2000-09       Impact factor: 17.425

2.  Neutrophil count is the most important prognostic component of the differential white cell count in patients undergoing elective surgery for colorectal cancer.

Authors:  David G Watt; John C Martin; James H Park; Paul G Horgan; Donald C McMillan
Journal:  Am J Surg       Date:  2015-03-12       Impact factor: 2.565

3.  Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma.

Authors:  Yukiyasu Okamura; Ryo Ashida; Takaaki Ito; Teiichi Sugiura; Keita Mori; Katsuhiko Uesaka
Journal:  World J Surg       Date:  2015-06       Impact factor: 3.352

4.  Hepatic resection for hepatocellular carcinoma -- Japanese experience.

Authors:  M Makuuchi; T Takayama; K Kubota; W Kimura; Y Midorikawa; S Miyagawa; S Kawasaki
Journal:  Hepatogastroenterology       Date:  1998-08

Review 5.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

6.  Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey.

Authors:  Susumu Eguchi; Takashi Kanematsu; Shigeki Arii; Masatoshi Okazaki; Kiwamu Okita; Masao Omata; Iwao Ikai; Masatoshi Kudo; Masamichi Kojiro; Masatoshi Makuuchi; Morito Monden; Yutaka Matsuyama; Yasuni Nakanuma; Kenichi Takayasu
Journal:  Surgery       Date:  2008-04       Impact factor: 3.982

7.  Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.

Authors:  Mitsuru Ishizuka; Hitoshi Nagata; Kazutoshi Takagi; Yoshimi Iwasaki; Norisuke Shibuya; Keiichi Kubota
Journal:  Ann Surg Oncol       Date:  2015-11-03       Impact factor: 5.344

8.  The inflammation-based scores to predict prognosis of patients with hepatocellular carcinoma after hepatectomy.

Authors:  Junting Huang; Li Xu; Yaoling Luo; Fengying He; Yaojun Zhang; Minshan Chen
Journal:  Med Oncol       Date:  2014-02-18       Impact factor: 3.064

9.  Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer.

Authors:  Xuechao Liu; Xiaowei Sun; Jianjun Liu; Pengfei Kong; Shangxiang Chen; Youqing Zhan; Dazhi Xu
Journal:  Transl Oncol       Date:  2015-08       Impact factor: 4.243

10.  Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection.

Authors:  Weijia Liao; Jingmei Zhang; Qun Zhu; Liling Qin; Wenmin Yao; Biao Lei; Wuxiang Shi; Shengguang Yuan; Syed Abdul Tahir; Junfei Jin; Songqing He
Journal:  Transl Oncol       Date:  2014-03-04       Impact factor: 4.243

View more
  7 in total

1.  Relationship between disease impact scores and C-reactive protein/albumin ratio in patients with psoriatic arthritis.

Authors:  Tugba Izci Duran; Melih Pamukcu
Journal:  Croat Med J       Date:  2022-04-30       Impact factor: 2.415

2.  Prognostic impact of C-reactive protein-albumin ratio for the lethality in castration-resistant prostate cancer.

Authors:  Taizo Uchimoto; Kazumasa Komura; Yuya Fujiwara; Kenkichi Saito; Naoki Tanda; Tomohisa Matsunaga; Atsushi Ichihashi; Takeshi Tsutsumi; Takuya Tsujino; Yuki Yoshikawa; Yudai Nishimoto; Tomoaki Takai; Koichiro Minami; Kohei Taniguchi; Tomohito Tanaka; Hirofumi Uehara; Hajime Hirano; Hayahito Nomi; Naokazu Ibuki; Kiyoshi Takahara; Teruo Inamoto; Haruhito Azuma
Journal:  Med Oncol       Date:  2019-11-21       Impact factor: 3.064

3.  Clinical significance of systemic immune-inflammation index (SII) and C-reactive protein-to-albumin ratio (CAR) in patients with esophageal cancer: a meta-analysis.

Authors:  Yi Zhang; Guoliang Xiao; Rong Wang
Journal:  Cancer Manag Res       Date:  2019-05-07       Impact factor: 3.989

4.  Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma.

Authors:  Peng Li; Wei Huang; Feng Wang; Ye-Fang Ke; Lin Gao; Ke-Qing Shi; Meng-Tao Zhou; Bi-Cheng Chen
Journal:  Biosci Rep       Date:  2018-11-13       Impact factor: 3.840

5.  Verification of inflammation-based prognostic marker as a prognostic indicator in hepatocellular carcinoma.

Authors:  Masateru Yamamoto; Tsuyoshi Kobayashi; Shintaro Kuroda; Michinori Hamaoka; Sho Okimoto; Naruhiko Honmyo; Megumi Yamaguchi; Hideki Ohdan
Journal:  Ann Gastroenterol Surg       Date:  2019-09-20

Review 6.  Clinical Significance of C-Reactive Protein to Albumin Ratio in Patients with Hepatocellular Carcinoma: A Meta-Analysis.

Authors:  Nanping Lin; Jingrong Li; Qiao Ke; Lei Wang; Yingping Cao; Jingfeng Liu
Journal:  Dis Markers       Date:  2020-09-02       Impact factor: 3.434

7.  The prognostic value of the C-reactive protein to albumin ratio in cancer: An updated meta-analysis.

Authors:  Xinhua Cui; Zhiqiang Jia; Dingchao Chen; Chunwei Xu; Peng Yang
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.